Article Details

Biotech Launches Trial Dosing Against Backdrop of Strong Balance Sheet

Retrieved on: 2018-03-07 02:33:45

Tags for this article:

Click the tags to see associated articles and topics

Biotech Launches Trial Dosing Against Backdrop of Strong Balance Sheet. View article details on hiswai:

Excerpt

<div>As of February 28, 2018, neither the Firm nor its affiliates beneficially own 1% or more of any class of common <b>equity securities</b> of DURECT Corporation. Neither the research analyst nor the Firm has any material conflict of interest in of which the research analyst knows or has reason to know at the time ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up